UniQure N.V. (NASDAQ: QURE) and Apic Bio entered into a global licensing agreement for APB-102 to treat superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS).
Letter of Intent with Sanity Group
High Tide also announced that it has entered into a non-binding letter of intent (the "LOI") with the Berlin-based health and life science company, Sanity
Ritedose, a 503B outsourcing facility located in South Carolina, has been awarded a group purchasing agreement with Premier Inc., a leading healthcare improvement company operating one of the nation's
American Rheinmetall Vehicles (Sterling Heights, MI) and GM Defense LLC (Washington, DC) have won a contract for the first phase of the U.S. Army's Common Tactical Truck (CTT) Program. The aim of the multi-phased program is to replace the Army's family of heavy tactical trucks with production of up to 40,000 trucks valued at up to $14 billion.
Kite, a Gilead Company (NASDAQ:GILD), and Arcellx, Inc. (NASDAQ:ACLX), today announced the closing of the companies' previously announced global strategic collaboration to co-develop and co-commercialize